Chronic Kidney Disease Epidemiology Analysis and Forecast to 2031

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Chronic Kidney Disease Epidemiology Analysis Report Overview

The total prevalent cases of chronic kidney disease (CKD) were 103,485,844 cases in 2021 in the 7 major markets (7MM). The number of cases is expected to increase at an annual growth rate (AGR) of more than 1% during the forecast period. Chronic kidney disease or chronic renal disease, is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulation of excess fluid and waste in the body. In the early stages, chronic kidney disease is a largely asymptomatic condition. As the disease progresses, the symptoms worsen and eventually lead to kidney failure.

Chronic Kidney Disease Market Overview, 2021 (No of Cases)

Chronic Kidney Disease Market Overview, 2021 (No of Cases)

To gain more information on the chronic kidney disease market forecast, download a free report sample

Each stage of CKD requires different diagnostic tests and treatments for the management of the disease. Currently, there is no cure for CKD, but treatments can slow the progression of the disease. Additionally, CKD patients are advised to undergo renal replacement therapy (RRT) when the kidneys fail in the advanced stages of the disease. RRT includes renal dialysis and kidney transplantation, which help to sustain and maintain life, blood pressure (BP), the balance of chemicals (electrolytes) for the functioning of the heart and muscles, and the production of vitamin D and red blood cells in CKD patients (Levin et al., 2013).

The chronic kidney disease market research report provides an overview of the risk factors, comorbidities, and global and historical trends for CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It also includes a 10-year epidemiological forecast for total prevalent cases and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age, sex, and stage in these markets.

Market size (2021) 103,485,844 cases
AGR >1%
Forecast period 2021-2031
7 major markets (7MM) The US, France, Germany, Italy, Spain, the UK, and Japan
Key age segments 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
Key sex segments Men and Women
Key stage Stage I, Stage II, Stage IIIa, Stage IIIb, Stage IV, And Stage V
Key dialysis dependence types Non-Dialysis Dependent and Dialysis Dependent

Chronic Kidney Disease Market Segmentation by Age

The chronic kidney disease market can be segmented based on age into 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.

In 2021, for the 7MM combined, adults ages 70–79 years contributed the highest proportion of the diagnosed prevalent cases of chronic kidney disease followed by the age group 60–69 years and ages 80 years and older.

Chronic Kidney Disease Market Analysis by Age, 2021 (%)

Chronic Kidney Disease Market Analysis by Age

For more age segment insights, download a free report sample

Chronic Kidney Disease Market Segmentation by Sex

The chronic kidney disease market can be segmented based on sex into men and women.

In the 7MM combined, the number of diagnosed prevalent cases of CKD was higher in women than in men in 2021. However, in Germany and Japan, the number of diagnosed prevalent cases of CKD was observed to be higher in men than in women. France had the smallest variation in the number of diagnosed prevalent cases between men and women.

Chronic Kidney Disease Market Analysis by Sex, 2021 (%)

Chronic Kidney Disease Market Analysis by Sex

For more sex segment insights, download a free report sample

Chronic Kidney Disease Market Segmentation by Stages

The chronic kidney disease market can be further divided into six stages: stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V.

In the 7MM, the highest number of diagnosed prevalent cases of CKD was in stage IIIa followed by stages IIIb and stage II. Among the 7MM, Japan had the highest number of diagnosed prevalent cases of CKD in stage IIIa followed by the US. This difference in stage-specific diagnosed prevalent cases might be driven by the varying stage-specific diagnosis rate in the markets.

Chronic Kidney Disease Market Analysis by Stages, 2021 (%)

Chronic Kidney Disease Market Analysis by Stages

For more stage insights, download a free report sample

Chronic Kidney Disease Market Segmentation by Dialysis Dependence Types

The chronic kidney disease market can be divided into two types based on dialysis dependence: non-dialysis dependent and dialysis dependent.

In the 7MM, the US had the highest number of diagnosed prevalent cases of CKD that were non-dialysis dependent followed by Japan and Germany. For dialysis-dependent CKD, the US had the highest number of diagnosed prevalent cases followed by Japan and Germany.

Chronic Kidney Disease Market Analysis by Dialysis Dependence, 2021(%)

Chronic Kidney Disease Market Analysis by Dialysis Dependence

For more insights on dialysis dependence types, download a free report sample

Chronic Kidney Disease 7 Major Markets

The 7 major markets in chronic kidney disease are the US, France, Germany, Italy, Spain, the UK, and Japan.

It is expected that, in 2031, the US will have the highest number of diagnosed prevalent cases of CKD in the 7MM and Italy will have the fewest diagnosed prevalent cases of CKD.

Reasons to Buy

  • The Chronic Kidney Disease Epidemiology series will allow you to:
  • Develop business strategies by understanding the trends shaping and driving the global CKD market.
  • Quantify patient populations in the global CKD market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CKD therapeutics in each of the markets covered.
  • Understand the magnitude of CKD population by subtype, digital vasculopathy, and other internal organ involvement.

Table of Contents

| About GlobalData

1 Chronic Kidney Disease: Executive Summary

1.1 Catalyst

1.2 Related Reports

1.3 Upcoming Reports

2 Epidemiology

2.1 Disease Background

2.2 Risk Factors and Comorbidities

2.3 Global and Historical Trends

2.4 7MM Forecast Methodology

2.4.1 Sources

2.4.2 Forecast Assumptions and Methods

2.4.3 Total Prevalent Cases of CKD

2.4.4 Total Prevalent Cases of CKD by Stage

2.4.5 Diagnosed Prevalent Cases of CKD

2.4.6 Diagnosed Prevalent Cases of CKD by Stage

2.4.7 Diagnosed Prevalent Cases of CKD Based on Dialysis Dependence

2.5 Epidemiological Forecast for CKD (2021–31)

2.5.1 Total Prevalent Cases of CKD

2.5.2 Total Prevalent Cases of CKD by Stage

2.5.3 Diagnosed Prevalent Cases of CKD

2.5.4 Age-Specific Diagnosed Prevalent Cases of CKD

2.5.5 Sex-Specific Diagnosed Prevalent Cases of CKD

2.5.6 Diagnosed Prevalent Cases of CKD by Stage

2.5.7 Diagnosed Prevalent Cases of CKD by Dialysis Dependence

2.6 Discussion

2.6.1 Epidemiological Forecast Insight

2.6.2 COVID-19 Impact

2.6.3 Limitations of the Analysis

2.6.4 Strengths of the Analysis

3 Appendix

3.1 Bibliography

3.2 About the Authors

3.2.1 Epidemiologist

3.2.2 Reviewers

3.2.3 Global Director of Therapy Analysis and Epidemiology

3.2.4 Global Head and EVP of Healthcare Operations and Strategy

| Contact Us

Table

Table 1: Summary of updated data types

Table 2: KDIGO classification of CKD

Table 3: Risk factors and comorbid conditions associated with CKD

Figures

Figure 1: 7MM, total prevalent cases of CKD, both sexes, N, ages ≥18 years, 2021 and 2031

Figure 2: 7MM, diagnosed prevalent cases of CKD, both sexes, N, ages ≥18 years, 2021 and 2031

Figure 3: 7MM, diagnosed prevalence of CKD (%), men, ages ≥18 years, 2021

Figure 4: 7MM, sources used and not used to forecast the total and diagnosed prevalent cases of CKD

Figure 5: 7MM, sources used to forecast the total prevalent cases of CKD by stage

Figure 6: 7MM, sources used to forecast the diagnosed prevalent cases of CKD by stage

Figure 7: 7MM, sources used to forecast the diagnosed prevalent cases of CKD by dialysis dependence

Figure 8: 7MM, total prevalent cases of CKD, N, both sexes, ages ≥18 years, 2021

Figure 9: 7MM, total prevalent cases of CKD by stage, N, both sexes, ages ≥18 years, 2021

Figure 10: 7MM, diagnosed prevalent cases of CKD, N, both sexes, ages ≥18 years, 2021

Figure 11: 7MM, diagnosed prevalent cases of CKD by age group, N, both sexes, 2021

Figure 12: 7MM, diagnosed prevalent cases of CKD by sex, N, ages ≥18 years, 2021

Figure 13: 7MM, diagnosed prevalent cases of CKD by stage, N, both sexes, ages ≥18 years, 2021

Figure 14: 7MM, diagnosed prevalent cases of CKD by dialysis dependence, N, both sexes, ages ≥18 years, 2021

Figure 15: 7MM, diagnosed prevalent cases of CKD based on dialysis-dependent subtype, N, both sexes, ages ≥18 years, 2021

Frequently asked questions

Chronic Kidney Disease Epidemiology Analysis and Forecast to 2031 thematic reports
Currency USD
$3,995

Can be used by individual purchaser only

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Chronic Kidney Disease Epidemiology Analysis and Forecast to 2031 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Chronic Kidney Disease Epidemiology Analysis and Forecast to 2031 in real time.

  • Access a live Chronic Kidney Disease Epidemiology Analysis and Forecast to 2031 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.